Insider Transactions in Q1 2025 at Eye Point Pharmaceuticals, Inc. (EYPT)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 06
2025
|
Jay S. Duker President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,108
-7.75%
|
$48,864
$8.68 P/Share
|
|
Jan 06
2025
|
Jay S. Duker President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,794
+20.88%
|
-
|
|
Jan 06
2025
|
Nancy Lurker |
BUY
Exercise of conversion of derivative security
|
Direct |
75,134
+28.83%
|
-
|
|
Jan 06
2025
|
George Elston Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,808
-6.55%
|
$38,464
$8.68 P/Share
|
|
Jan 06
2025
|
George Elston Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,285
+17.24%
|
-
|
|
Jan 05
2025
|
Jay S. Duker President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,007
-14.71%
|
$80,056
$8.26 P/Share
|
|
Jan 05
2025
|
Jay S. Duker President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+30.6%
|
-
|
|
Jan 05
2025
|
John B. Landis |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+31.85%
|
-
|
|
Jan 05
2025
|
Nancy Lurker |
BUY
Exercise of conversion of derivative security
|
Direct |
12,667
+10.3%
|
-
|
|
Jan 05
2025
|
George Elston Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,267
-8.31%
|
$42,136
$8.26 P/Share
|
|
Jan 05
2025
|
George Elston Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+19.14%
|
-
|